Henrique Mora

Dr. Henrique Mora

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in The Lancet Global Health
Verified
Journal Article
Open access
CSCatherine A Shaw
Catherine A Shaw
RPRiinu Pius
Riinu Pius
TDThomas M Drake
Thomas M Drake
LNLisa Norman
Lisa Norman
AAAdesoji O Ademuyiwa
Adesoji O Ademuyiwa
JLJean Wilguens Lartigue
Jean Wilguens Lartigue
Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. National Institute for Health and Care Research.

23 November 2023 in Surgical Oncology
Verified
Journal Article
Open access
TPTiago Russell Pinto
Tiago Russell Pinto
HMHenrique Mora
Henrique Mora
BPBárbara Peleteiro
Bárbara Peleteiro
AMAndré Magalhães
André Magalhães
DGDiana Gonçalves
Diana Gonçalves
JFJosé Fougo
José Fougo
Breast-conserving surgery associated with adjuvant radiotherapy is the state of the art in the surgical treatment of breast cancer. Oncoplastic surgery through dermo-adipose flaps based in perforating arteries (muscle sparing flaps) for partial reconstruction is increasingly used as a good option for avoiding musculocutaneous flaps. In this study we evaluate the outcomes of the use of chest wall perforator flaps in the replacement of partial breast volume. A prospective cohort study of female patients that underwent a conservative oncoplastic surgery procedure with partial breast reconstruction using a dermo-adipose flap of perforating arteries of the chest wall was conducted between November 2020 and March 2022 at our centre. Primary outcomes were surgical morbidity, positive margins and reoperation rates. Characteristics associated with the occurrence of complications were further identified. Forty-five patients underwent the procedure of interest during the study period. The mean age was 55 years. The median larger dimension of the tumor was 23 mm. Lateral intercostal artery perforator (LICAP), lateral thoracic artery perforator (LTAP), a combined flap and Anterior Intercostal Artery Perforator/Medial Intercostal Artery Perforator (AICAP)/(MICAP) were performed in 22, 16, 2 and 5 patients, respectively. The mean operative time was 126 min. A total of 9 (20.0%) patients required a reoperation after definitive diagnosis, 4 due to positive margins and 5 due to immediate/early surgical morbidity. Local perforator flaps in oncoplastic breast-conserving surgery are a good option for immediate reconstruction after conservative surgery, showing low morbidity and favourable outcomes.

20 October 2021 in Medicines
Verified
Journal Article
Open access
PDF file
JNJorge Nogueiro
Jorge Nogueiro
VDVítor Devezas
Vítor Devezas
FSFabiana Silva Sousa
Fabiana Silva Sousa
CFCristina Fernandes
Cristina Fernandes
FOFernando Osorio
Fernando Osorio
EBElisabete Barbosa
Elisabete Barbosa
Introduction: Breast cancer is the most incident cancer in the world, accounting for 25% of new cancers per year in females. It is the most frequent malignancy in women, being the fifth cause of death from cancer worldwide. Approximately 5 to 10% of patients already present with metastases at diagnosis, and the liver is the site of metastases in half of these cases. Liver metastasis (LM) resection, performed after neoadjuvant systemic treatment, has been reported to increase median overall survival in this population. Aim: The aim of this analysis is to assess the outcomes of patients undergoing breast cancer liver metastasis surgical resection, including impact on survival, compared to patients where metastasectomy was not performed. Methods: retrospective review of 55 female patients with breast cancer liver metastases, diagnosed and treated in a single tertiary university hospital from January 2011 to December 2016 was performed. Results: In 32/55 patients (58.2%), multi-organ metastases were identified (the most common sites being bone, lungs, and lymph nodes). Of the remaining 23 patients, the liver was the unique metastatic site; thirteen patients had diffuse bilobar hepatic metastases. The remaining ten patients were proposed for surgical treatment; three of them had peritoneal carcinomatosis identified during surgery, and no hepatic metastasectomy was performed. As a result, only seven (12.7%) patients underwent liver metastasectomy. Overall survival was higher in patients who had LM surgery (65 months [Interquartile Range (IQR) 54–120]), in comparison to those diagnosed with diffuse bilobar hepatic metastases (17.5 months [IQR 11–41]), and with those showing concurrent liver and bone metastases (16.5 months [IQR 6–36]) (p = 0.012). In univariable analysis, the latter two groups showed worse overall survival outcomes (Hazard Ratio (HR) = 3.447, 95%CI: 1.218–9.756, p = 0.02 and HR = 3.855, 95% Confidence Interval (CI): 1.475–10.077, p = 0.006, respectively) when compared to patients with LM. Conclusion: In our series, patients submitted to metastasectomy had a median overall survival after diagnosis of LM three times greater than the non-operated patients with isolated LM, or concurrent LM and bone metastases (65 vs. 17.5 and 16.5 months, respectively). As is vastly known for colorectal cancer liver metastasis, resection of breast cancer liver metastasis may reduce tumor burden, and therefore may improve patient outcome.

24 February 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
JNJorge Nogueiro
Jorge Nogueiro
VDVítor Devezas
Vítor Devezas
APAndré Pereira
André Pereira
FGFabio Gomes
Fabio Gomes
FSFabiana Silva Sousa
Fabiana Silva Sousa
EBElisabete Barbosa
Elisabete Barbosa

26 August 2026 in Clinical Breast Cancer
Verified
Journal Article
Open access
HMHenrique Mora
Henrique Mora
DCDiogo Cruz
Diogo Cruz
DGDiana Gonçalves
Diana Gonçalves
BPBárbara Peleteiro
Bárbara Peleteiro
JFJosé Fougo
José Fougo
Achieving negative margins at the first operation is a central goal of breast-conserving surgery (BCS), yet positive margins and re-excision remain common. Conventional preoperative magnetic resonance imaging (MRI) is acquired in the prone position, a position the breast does not assume during surgery, and the resulting prone-to-supine deformation may degrade image transfer to the operative field. Supine MRI (SMRI) has been proposed to overcome this limitation. This systematic review evaluated its effect on positive surgical margin and re-excision rates in BCS. Four databases were searched from inception to May 2026, with backward citation tracking. Absolute rates were summarized narratively by transfer technique; a post-hoc exploratory relative-risk meta-analysis was restricted to studies with a comparator. Thirteen studies (1718 patients) were included. Positive margin rates with SMRI ranged from 0% to 25.9%; heterogeneity in margin definitions precluded pooling of absolute rates. Across the 5 comparative studies, SMRI was associated with a significantly lower risk of a positive margin (relative risk [RR] 0.57 [95% confidence interval (CI), 0.36-0.88]) and a nonsignificant reduction in re-excision (RR 0.64 [95% CI, 0.40-1.04]), without detectable heterogeneity. The evidence base was limited: a single randomized trial and 11 of 12 nonrandomized studies at serious risk of bias, with baseline confounding that generally disfavored the intervention. SMRI is a biologically coherent and promising approach that may reduce positive margins, but current evidence is preliminary. Randomized comparison against contemporary localization techniques, using harmonized margin definitions, is required.